Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.
2.

Prognostic superiority of the National Comprehensive Cancer Network International Prognostic Index over pretreatment whole-body volumetric-metabolic FDG-PET/CT metrics in diffuse large B-cell lymphoma.

Adams HJ, de Klerk JM, Fijnheer R, Heggelman BG, Dubois SV, Nievelstein RA, Kwee TC.

Eur J Haematol. 2015 Jun;94(6):532-9. doi: 10.1111/ejh.12467. Epub 2015 Mar 13.

PMID:
25311082
3.

Standardized uptake value by positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer.

Morris PG, Ulaner GA, Eaton A, Fazio M, Jhaveri K, Patil S, Evangelista L, Park JY, Serna-Tamayo C, Howard J, Larson S, Hudis CA, McArthur HL, Jochelson MS.

Cancer. 2012 Nov 15;118(22):5454-62. doi: 10.1002/cncr.27579. Epub 2012 Apr 19.

4.

Whole-Body Metabolic Tumor Volume, as Determined by (18)F-FDG PET/CT, as a Prognostic Factor of Outcome for Patients With Breast Cancer Who Have Distant Metastasis.

Son SH, Lee SW, Jeong SY, Song BI, Chae YS, Ahn BC, Lee J.

AJR Am J Roentgenol. 2015 Oct;205(4):878-85. doi: 10.2214/AJR.14.13906. Epub 2015 Jul 23.

PMID:
26204115
5.

Quantitative metabolic parameters measured on F-18 FDG PET/CT predict survival after relapse in patients with relapsed epithelial ovarian cancer.

Kim CY, Jeong SY, Chong GO, Son SH, Jung JH, Kim DH, Lee SW, Ahn BC, Lee J.

Gynecol Oncol. 2015 Mar;136(3):498-504. doi: 10.1016/j.ygyno.2014.12.032. Epub 2014 Dec 31.

PMID:
25557270
6.

Prognostic significance of total lesion glycolysis in patients with advanced non-small cell lung cancer receiving chemotherapy.

Zaizen Y, Azuma K, Kurata S, Sadashima E, Hattori S, Sasada T, Imamura Y, Kaida H, Kawahara A, Kinoshita T, Ishibashi M, Hoshino T.

Eur J Radiol. 2012 Dec;81(12):4179-84. doi: 10.1016/j.ejrad.2012.07.009. Epub 2012 Aug 9.

PMID:
22884163
7.

Prognostic value of quantitative fluorodeoxyglucose measurements in newly diagnosed metastatic breast cancer.

Ulaner GA, Eaton A, Morris PG, Lilienstein J, Jhaveri K, Patil S, Fazio M, Larson S, Hudis CA, Jochelson MS.

Cancer Med. 2013 Oct;2(5):725-33. doi: 10.1002/cam4.119. Epub 2013 Sep 12.

8.

Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.

De Giorgi U, Valero V, Rohren E, Dawood S, Ueno NT, Miller MC, Doyle GV, Jackson S, Andreopoulou E, Handy BC, Reuben JM, Fritsche HA, Macapinlac HA, Hortobagyi GN, Cristofanilli M.

J Clin Oncol. 2009 Jul 10;27(20):3303-11. doi: 10.1200/JCO.2008.19.4423. Epub 2009 May 18.

PMID:
19451443
9.

Total lesion glycolysis: a possible new prognostic parameter in oral cavity squamous cell carcinoma.

Abd El-Hafez YG, Moustafa HM, Khalil HF, Liao CT, Yen TC.

Oral Oncol. 2013 Mar;49(3):261-8. doi: 10.1016/j.oraloncology.2012.09.005. Epub 2012 Oct 1.

PMID:
23036774
10.

FDG Avidity and Tumor Burden: Survival Outcomes for Patients With Recurrent Breast Cancer.

Taghipour M, Wray R, Sheikhbahaei S, Wright JL, Subramaniam RM.

AJR Am J Roentgenol. 2016 Apr;206(4):846-55. doi: 10.2214/AJR.15.15106. Epub 2016 Feb 25.

PMID:
27003053
12.

The maximum standardized uptake value of metastatic site in 18 F-FDG PET/CT predicts molecular subtypes and survival in metastatic breast cancer: An Izmir Oncology Group study.

Cokmert S, Tanriverdi O, Karapolat I, Demir L, Bayoglu V, Can A, Akyol M, Yilmaz Y, Oktay Tarhan M.

J BUON. 2016 Nov-Dec;21(6):1410-1418.

PMID:
28039701
13.

Clinical significance of pretreatment metabolic tumor volume and total lesion glycolysis in hypopharyngeal squamous cell carcinomas.

Roh JL, Kim JS, Kang BC, Cho KJ, Lee SW, Kim SB, Choi SH, Nam SY, Kim SY.

J Surg Oncol. 2014 Dec;110(7):869-75. doi: 10.1002/jso.23729. Epub 2014 Aug 2.

PMID:
25088392
14.

Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.

Pace L, Nicolai E, Luongo A, Aiello M, Catalano OA, Soricelli A, Salvatore M.

Eur J Radiol. 2014 Feb;83(2):289-96. doi: 10.1016/j.ejrad.2013.11.002. Epub 2013 Nov 23.

PMID:
24331845
15.

18F-fluorodeoxyglucose--positron emission tomography/computed tomography aids staging and predicts mortality in patients with muscle-invasive bladder cancer.

Mertens LS, Mir MC, Scott AM, Lee ST, Fioole-Bruining A, Vegt E, Vogel WV, Manecksha R, Bolton D, Davis ID, Horenblas S, van Rhijn BW, Lawrentschuk N.

Urology. 2014 Feb;83(2):393-8. doi: 10.1016/j.urology.2013.10.032. Erratum in: Urology. 2014 Jun;83(6):1447. Davies, Ian [corrected to Davis, Ian D].

PMID:
24468513
16.

Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer--usefulness for malignant grade of triple-negative breast cancer.

Ohara M, Shigematsu H, Tsutani Y, Emi A, Masumoto N, Ozaki S, Kadoya T, Okada M.

Breast. 2013 Oct;22(5):958-63. doi: 10.1016/j.breast.2013.05.003. Epub 2013 Jun 10.

PMID:
23756383
17.

Role of positron emission tomography/computed tomography findings for adjuvant chemotherapy indications in stage T1b-2aN0M0 lung adenocarcinoma.

Sasada S, Miyata Y, Tsubokawa N, Mimae T, Yoshiya T, Okada M.

Ann Thorac Surg. 2014 Aug;98(2):417-22. doi: 10.1016/j.athoracsur.2014.04.080. Epub 2014 Jun 21.

PMID:
24961842
18.

Prognostic value of total lesion glycolysis by 18F-FDG PET/CT in surgically resected stage IA non-small cell lung cancer.

Park SY, Cho A, Yu WS, Lee CY, Lee JG, Kim DJ, Chung KY.

J Nucl Med. 2015 Jan;56(1):45-9. doi: 10.2967/jnumed.114.147561. Epub 2014 Dec 18.

19.

Prognostic implication of extrarenal metabolic tumor burden in advanced renal cell carcinoma treated with targeted therapy after nephrectomy.

Yoon HJ, Paeng JC, Kwak C, Park YH, Kim TM, Lee SH, Chung JK, Edmund Kim E, Lee DS.

Ann Nucl Med. 2013 Oct;27(8):748-55. doi: 10.1007/s12149-013-0742-4. Epub 2013 Jul 2.

PMID:
23818007
20.

Prognostic value of the quantitative metabolic volumetric measurement on 18F-FDG PET/CT in Stage IV nonsurgical small-cell lung cancer.

Liao S, Penney BC, Zhang H, Suzuki K, Pu Y.

Acad Radiol. 2012 Jan;19(1):69-77. doi: 10.1016/j.acra.2011.08.020.

PMID:
22142679

Supplemental Content

Support Center